Results 91 to 100 of about 1,716,393 (201)

Environmental Surveillance of Poliovirus in the Democratic Republic of the Congo: Sensitivity and Site Productivity, 2017–2025

Pathogens
Background: Environmental surveillance (ES) of wastewater was introduced by the Global Polio Eradication Initiative (GPEI) to improve the sensitivity of acute flaccid paralysis (AFP) surveillance.
Vanessa Bakumba-Kiulu, Paul Tshiminyi-Munkamba, Trésor Kabeya-Mampuela, Meris Matondo-Kuamfumu, Grace Kashitu-Mujinga, Junior Bulabula-Penge, Elisabeth Pukuta-Nsimbu, Elysabeth Muyamuna-Mulongo, Yvonne Lay Mowele, Jean Claude Mukangala-Changa-Changa, Eddy Kinganda-Lusamaki, Narcisse Yogolelo-Riziki, Antoine Nkuba-Ndaye, Steve Ahuka-Mundeke   +13 more
doaj   +1 more source

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.

PLoS ONE, 2016
BackgroundThe "gold standard" for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV).
Ayan Dey, Natalie A Molodecky, Harish Verma, Prashant Sharma, Jae Seung Yang, Giulietta Saletti, Mohammad Ahmad, Sunil K Bahl, Thomas F Wierzba, Ranjan K Nandy, Jagadish M Deshpande, Roland W Sutter, Cecil Czerkinsky   +12 more
doaj   +1 more source

Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial. [PDF]

Vaccine, 2023
Snider CJ, Zaman K, Wilkinson AL, Binte Aziz A, Yunus M, Haque W, Jones KAV, Wei L, Estivariz CF, Konopka-Anstadt JL, Mainou BA, Patel JC, Lickness JS, Pallansch MA, Wassilak SGF, Steven Oberste M, Anand A.   +16 more
europepmc   +1 more source

Biologicals [PDF]

According to manufacturers, inactivated poliovirus vaccines (IPVs) are freeze sensitive and require storage between 2\ub0C and 8\ub0C, whereas oral poliovirus vaccine requires storage at -20\u202f\ub0C.

core  

Certification of the industry reference standard for the specific activity of «BiVac polio» - live attenuated bivalent oral polio vaccine type 1 and 3

Биопрепараты: Профилактика, диагностика, лечение, 2018
The standardization and control of «BiVac polio» (live attenuated bivalent oral polio vaccine type 1 and 3) developed by M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides of the Russian Academy of Medical Sciences, called for ...
E. V. Karpova, A. D. Sangadzhieva, T. V. Mamontova, O. V. Fadeykina, R. A. Volkova, K. A. Sarkisyan, A. A. Movsesyants   +6 more
doaj  

Polio: Background and perspective on how international travel can be made safe against polio

Therapeutic Advances in Infectious Disease
International spread of polio continues to be a Public Health Emergency of International Concern since its declaration by the World Health Organization in 2014 and its reiteration in 2024.
Dhanya Dharmapalan, Thekkekara Jacob John, Robert Steinglass, Norbert Hirschhorn   +3 more
doaj   +1 more source

Polio eradication in Ghana: past, present, and future

Frontiers in Tropical Diseases
IntroductionGhana joined the Global Polio Eradication Initiative in 1996 to interrupt wild poliovirus transmission in the country. This was a collaborative effort by the Ghana Health Service (Disease Surveillance Department and the Expanded Program on ...
John Kofi Odoom, Dennis Odai Laryea, Nana Afia Asante Ntim, Keren Attiku, Michael Adjabeng, Ewurabena Oduma Duker, Comfort Nuamah Antwi, Emmanuel Gberbi, Isaac Baffoe-Nyarko, Patience Lartekai Adams, Angelina Evelyn Dickson, Jessica Dufie Boakye, Jude Yayra Mensah, Christabel Odoom, Sharon Ansong Bimpong, Deborah Odame, Gayheart Deladem Agboste, Nancy Odoom, Franklin Asiedu-Bekoe, Evangeline Obodai   +19 more
doaj   +1 more source

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use

, 2017
Background: After stopping serotype 2–containing oral poliovirus vaccine use, serotype 2 poliovirus outbreaks may still occur and require outbreak response supplemental immunization activities (oSIAs).
Kimberly M. Thompson ScD, Kimberly M. Thompson, Radboud J. Duintjer Tebbens PhD, Radboud J. Duintjer Tebbens   +3 more
core   +1 more source

Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns. [PDF]

NPJ Vaccines, 2023
Walter KS, Altamirano J, Huang C, Carrington YJ, Zhou F, Andrews JR, Maldonado Y.   +6 more
europepmc   +1 more source

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

Frontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source